Abiopharma

Clinical trial NCT05328908: enrollment: 770 → 769 participants.

Clinical trial NCT04771650 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2028-08-01 → 2026-03-16 3. primary completion date: 2027-04-25 → 2026-03-16 4. enrollment: 220 → 91 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03135847 updates: 1. completion date: 2026-06-01 → 2028-06-01 2. primary completion date: 2026-06-01 → 2028-06-01

Clinical trial NCT07419334: start date: 2026-06-01 → 2026-06-03.

Clinical trial NCT06071767: status: RECRUITING → SUSPENDED.

Clinical trial NCT05371964 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 36 → 30 participants 3. enrollment type: ESTIMATED → ACTUAL 4. allocation: NA → NON_RANDOMIZED

Clinical trial NCT05394064: enrollment: 8 → 9 participants.

Clinical trial NCT07310992 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-01-15 → 2026-03-03

Clinical trial NCT07706166 updates: 1. start date: 2026-08-01 → 2026-09-01 2. completion date: 2029-08-01 → 2029-09-01 3. primary completion date: 2029-08-01 → 2029-09-01

Clinical trial NCT07383506: start date: 2026-06-01 → 2026-07-23.

Clinical trial NCT07310420 updates: 1. completion date: 2027-03-30 → 2027-07-31 2. primary completion date: 2026-11-30 → 2027-03-30 3. enrollment: 88 → 176 participants

Clinical trial NCT07549490: start date: 2026-08-30 → 2026-08-31.

Clinical trial NCT06173661 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-07-13 3. primary completion date: 2026-07-01 → 2026-05-05 4. enrollment: 72 → 15 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06016920 updates: 1. completion date: 2028-01-01 → 2030-12-01 2. primary completion date: 2027-09-01 → 2029-01-01 3. enrollment: 51 → 110 participants 4. allocation: NON_RANDOMIZED → RANDOMIZED 5. intervention model: SEQUENTIAL → PARALLEL

Clinical trial NCT06350097: completion date: 2032-05-25 → 2031-08-29.